Verzenio 150 mg/1

Verzenio 150 mg tablets are a prescription medication used in cancer treatment. This oral tablet, manufactured by Eli Lilly and Company, is designed to target specific proteins involved in cell growth.

Verzenio 150 mg tablets are commonly used in the treatment of certain types of cancer. This medication works by inhibiting proteins that play a role in the growth and division of cancer cells. It is often prescribed as part of a comprehensive treatment plan, which may include other therapies. Verzenio is used for advanced or metastatic breast cancer, particularly in patients with specific genetic markers.

Common effects of Verzenio 150 mg tablets may include fatigue, nausea, and diarrhea. Some users may experience a decrease in appetite or changes in blood cell counts. It is important to monitor for any unusual symptoms and consult a healthcare provider if significant side effects occur.

Verzenio 150 mg tablets should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may interact with other drugs, so it is crucial to inform your healthcare provider about all medications you are taking.

Verzenio 150 mg tablets may interact with certain medications, including those that affect liver enzymes. It is important to avoid grapefruit and grapefruit juice, as they can interfere with the metabolism of this medication. Always consult a healthcare provider before starting or stopping any medication while taking Verzenio.